Related Experiment Video
Updated: Jun 1, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Reference ranges for serum S100B protein during the first three years of life
Damien Bouvier1, Christoph Castellani, Mathilde Fournier
1Clermont-Ferrand Teaching Hospital, Biochemistry Department, Clermont-Ferrand, France.
Insights
This study establishes blood S100B reference ranges for children under 3 years, aiding traumatic brain injury diagnosis. These findings offer crucial data for pediatric clinical management.
Area of Science:
- Pediatric Medicine
- Biomarker Research
- Neurology
Background:
- Traumatic brain injuries (TBIs) pose diagnostic challenges in young children.
- S100B is a well-established biomarker for TBIs.
- Establishing age-specific reference ranges is critical for accurate interpretation.
Purpose of the Study:
- To determine blood S100B reference ranges in healthy children aged 0-3 years.
- To facilitate the clinical and diagnostic management of TBIs in this pediatric population.
- To provide a foundational dataset for future TBI research in young children.
Main Methods:
- Serum S100B concentrations were measured using electro-chemiluminescence immunoassay.
- A cohort of 186 healthy children aged 0-3 years was analyzed.
- Data were stratified into four age groups: 0-3, 4-9, 10-24, and 25-36 months.
Main Results:
- Defined S100B reference ranges for four distinct pediatric age cohorts.
- Identified an inverse correlation between S100B levels and head circumference.
- The study represents the largest cohort to date for S100B values in healthy children aged 0-3 years.
Conclusions:
- This research provides essential serum S100B values for healthy children aged 0-3 years.
- The established ranges support improved diagnostic accuracy for TBIs in young children.
- The findings contribute valuable data for pediatric clinical practice and TBI management.
Objective:
Clinical and diagnostic management of traumatic brain injuries is problematic in young children. To facilitate this management, we describe blood reference ranges for the well established biomarker S100B in children younger than 3 years.
Design And Methods:
Serum S100B concentrations were determined by electro-chemiluminescence immunoassay in a population of 186 healthy children aged 0-3 years.
Results:
Four age groups emerged, i.e. 0-3, 4-9, 10-24 and 25-36 months. We also found an interesting inverse correlation with head circumference.
Conclusion:
This study provides useful serum S100B values from the largest cohort of healthy children aged 0-3 years old.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Serum Studies: Renal Function Tests

